Please try another search
Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company engaged in the prevention and treatment of gastrointestinal (GI) disorders. The Company’s products are APRISO (mesalamine) indicated for the maintenance of remission of ulcerative colitis; COLAZAL (balsalazide disodium), treats mildly to moderately active ulcerative colitis, a form of inflammatory bowel disease with symptoms including bloody diarrhea and rectal bleeding; FULYZAQ (crofelemer) is an anti-diarrheal indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy; GIAZO (balsalazide disodium) is indicated for the treatment of mildly to moderately active ulcerative colitis (UC) in male patients 18 years of age and older; METOZOLV (metoclopramide HCl) ODT is orally disintegrating metoclopramide tablet, indicated for the relief of symptoms associated with acute and recurrent diabetic gastroparesis (gastric stasis) in adults; among others.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review